News Releases

-- Analysis of Phase 2 Study Demonstrates Acceptable Safety, Increased Glucose Metabolism, and Suggests Clinical Benefit in Mild Alzheimer's Disease Patients

Successful digital and mobile health technologies must address unmet needs, show clinical value, improve patient experience and be cost-effective

Five Presentations Include Non-Human Primate Data from Sangamo's In Vivo Protein Replacement Platform™ Approach for Hemophilia B, and Data from ZFN-Mediated Genome Editing Approach for Hemoglobinopathies

Festival Will Feature Top Financial Minds Discussing Important Market Themes for 2016

November 8 -11, 2015, Washington D.C. -- Registration Open

Concurrent shows create exceptional opportunity for two of America's biggest export industries in the U.A.E.

ChefTec Software Has Released Version xt5

Note: This release corresponds to ASH abstracts 29, 55, 57, 267, 377, 431, 469, 470, 495, 507, 508, 626, 699, 747, 833, 875, 894